CHUM

Diffusing alpha-emitters Radiation Therapy (Alpha DaRT) requires accurate placement of radioactive sources to ensure full coverage of the Gross Tumor Volume (GTV) while minimizing the required total number and length of implanted sources. We proposed a 3D clo...

In diffusing alpha-emitters radiation therapy (Alpha DaRT), the Diffusion-Leakage (DL) model is used to calculate the spread of radionuclides from unsealed sources implanted in a solid tumor. Various numerical methods for simulating the DL model have been pub...

To characterize patient‑specific quality assurance (PSQA) measurement frequency patterns across Canadian radiotherapy centers and to identify factors associated with reduced PSQA measurement frequency for routine VMAT and SBRT deliveries. The survey scope was...

To achieve accurate dosimetric modeling of Alpha DaRT sources by accounting for the spatial superposition of dose contributions from multiple implanted sources arranged in a regular lattice geometry.

Increasing international collaboration in radiation oncology highlights the need for standardized nomenclature that is consistent across languages. The AAPM Task Group TG‑263U1 established French and Spanish language sub‑groups in 2021 to support multilingual...

Calculation of the equivalent dose in Diffusing alpha-emitters Radiation Therapy (Alpha DaRT) depends strongly on the spatial dose distribution and the radiobiological impact of emitted alpha particles [1-3]. Current practice in clinical treatment planning sy...

This study aims to evaluate the effective RBE of recoiled nuclei and their contribution to equivalent dose estimation in Alpha DaRT, whose radiobiological impact remains poorly characterized.

A microfluidic lab-on-a-chip integrating an I-125 brachytherapy seed has recently been developed for radiobiological irradiation of spheroids. This study investigates a novel seed-through-film geometry suitable to validate the dosimetry of this device in the...